Additionally, elevated KIM-1 expression has been noted across a range of other cancers, including primary central nervous system lymphomas (54%), clear-cell ovarian carcinoma (93.8%), nephroblastomas (74%), endometrial carcinomas (33.3%), and germ cell tumors (50%). This evidence concerns the gene HAVCR1 and cancer.